Data / Form D filings / TB Biosciences, Inc.
TB Biosciences, Inc.: Form D filing
TB Biosciences, Inc., a biotechnology company in Bethlehem, PA, filed a Form D with the SEC in 2013. The latest, on June 12, 2013, reports $1.3 million sold of a $1.5 million offering to 9 investors.
Find out what TB Biosciences, Inc. does, who founded it and who invested, beyond what the filing says. $10 of credit on sign-up, no card.
SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.
Company details from the filing
- Address
- 205 WEBSTER STREET, Bethlehem, PA, 18015
- Phone
- (610) 597-5501
- Industry
- Biotechnology
- Entity type
- Corporation
- Incorporated in
- Delaware
- Year incorporated
- 2013
- Revenue range
- Decline to Disclose
- Exemptions claimed
- Rule 506
- SEC identifier (CIK)
- 1578956
The full lists. Form D filings in Pennsylvania: 987 rows, $49.35, or the new rows each week for $19 a month. Form D filings in Biotechnology: 1,568 rows, $78.40, or the new rows each week for $19 a month. Pay by card with no account. Prices exclude VAT. CSV and Excel files with the columns this page does not show (company, CIK, street, city, state, ZIP and 4 more), which open on your screen as soon as the payment clears and come by email. For agents and scripts: every list with its row count and price is at https://specstream.ai/data/lists.json.
Form D filings
| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
|---|---|---|---|---|---|---|---|
| Jun 12, 2013 | New notice | $1,500,000 | $1,250,000 | $250,000 | 9 | May 31, 2013 | sec.gov |
Executive officers and directors named in the filing
| Name | Role | Note in the filing |
|---|---|---|
| R. SAM NIEDBALA | Executive Officer, Director | |
| DAVID SAM OXELY | Director | |
| MICHAEL SAM GAUSLING | Director |
Other biotechnology companies in Pennsylvania that filed recently
- Traws Pharma, Inc. offering · Nov 5, 2026
- BioLattice Ophthalmics, Inc, $1.8 million · Oct 28, 2026
- Myris Therapeutics, Inc. $500,000 · Oct 14, 2026
- Praeventix, Inc. $5.6 million · Sep 10, 2026
- Plowshare Therapies LLC $6.7 million · Aug 31, 2026
- Noveome Biotherapeutics, Inc. $6.8 million · Aug 27, 2026
- AlloTRx Bio Inc. $500,000 · Aug 24, 2026
- Aposture Surgical Corp $87,000 · Aug 13, 2026
- Merlin Biotech, Inc. $50,000 · Aug 11, 2026
Every Form D from the week of Jun 10, 2013 · All recent filings in Pennsylvania · All recent Biotechnology filings
Read from SEC EDGAR. Amount sold is what TB Biosciences, Inc. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.
$10 of credit on sign-up, no card.